3M India Ltd
3MINDIA3M India Ltd is strength at full price. The numbers are improving — and a P/E at the 80th percentile of its own range says the market knows.
The sharpest disagreement: the engine is strong, but at the 80th percentile of its own range you are paying full price for it.
The price is in a confirmed uptrend (10 weeks in) while the P/E sits at the 80th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +30.9% year on year, and 96% of the last 3 years' profit arrived as cash. What settles it: whether the earnings grow into the multiple.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
3M India Ltd trades at ₹34,095, in a confirmed uptrend and 10 weeks into that stage. That is +2.1% against its own 200-day average. It sits at 57% of a 52-week range of ₹29,560 to ₹37,505. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week.
Today the stock is in a confirmed uptrend — week 10 of stage 2, confirmed. At ₹34,095 it trades +2.1% versus its 200-day average and sits at 57% of its 52-week range (₹29,560–₹37,505).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +216% while the NIFTY 500 moved +264% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
3M India Ltd trades at 87.2× P/E, at the pricey end of its own range (80th percentile). Its long-run median P/E is 72.7×, measured across 10.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 87.2× is at the pricey end of its own range (80th percentile), against a long-run median of 72.7× measured over 10.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +9.7% against a +14.0% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +6.2%/yr price move, ~+15.2%/yr came from earnings growth and ~−9.0 pp from the multiple (compressing); over 10y, of the +10.0%/yr price move, ~+7.3%/yr came from earnings growth and ~+2.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, 3M India Ltd was paying for profit growth of about 30.1% a year. Profit itself has compounded 10.3% a year over the past 10 years. Today the market pays 87.2× P/E, the 80th percentile of its own 10-year range.
What the two numbers say together. The multiple is full against its own past, and the growth the price is paying for is far above what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 18 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
3M India Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −17.0% at the trough to +16.1%, a 3-quarter improving streak, ROCE lifting at 47.5%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +14.5% | +10.9% | +16.0% | +9.1% |
| Profit | +9.7% | +7.9% | +28.5% | +10.3% |
| EPS | +9.7% | +7.9% | +28.5% | +10.4% |
| Share price | +14.0% | +3.9% | +6.2% | +10.0% |
4-Factor Sector Score
52.7/100 — rank 7 of 20 in Diversified · 94% evidence confidence
3M India Ltd scores 52.7 out of 100 against the 20 companies it is compared with in Diversified, ranking 7. Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
The four contributions add to the total exactly: 21.9 + 18.7 + 1.8 + 10.3 = 52.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
3M India Ltd reported ₹1,423 Cr of revenue in the Jun 26 quarter, +19.0% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 9.1% a year. The last full year, FY26, came in at ₹5,090 Cr. The last four reported quarters add to ₹5,316 Cr.
FY26 revenue came in at ₹5,090 Cr (+14.5% on the year), capping 10 years at 9.1% compound. The latest quarter (Jun 26) printed ₹1,423 Cr, +19.0% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +15.6% growth against the decade's 9.1% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +15.7% over the last 4 quarters against +13.5%/yr over the last 8 — stabilising; TTM profit +16.1% vs −1.9%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
3M India Ltd's operating margin is 17.0% in the Jun 26 quarter, −3.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged 6.0% to 19.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 17.0%, −3.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 6.0%–19.0%, and FY26's 19.0% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −3.5 pp year on year while gross margin went −4.7 pp — the loss came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
3M India Ltd earned ₹233 Cr of net profit in the Jun 26 quarter, +30.9% year on year. It is the 2nd consecutive quarter of growth. Full-year FY26 profit was ₹522 Cr. The 10-year compound rate is 10.3%. That is 16.4% of the quarter's revenue. The same quarter a year earlier earned ₹178 Cr.
Jun 26 profit was ₹233 Cr, +30.9% year on year — the 2nd consecutive quarter of growth. On the full year, FY26 printed ₹522 Cr (+9.7%), and the 10-year compound rate is 10.3%.
Why profit moved: revenue contributed +19.0% and the margin −3.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +30.5% vs revenue +15.6%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 96% of 3M India Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹514 Cr of operating cash against ₹522 Cr of profit. After ₹135 Cr of capital spending, ₹379 Cr was left as free cash.
FY26: operating cash of ₹514 Cr against reported profit of ₹522 Cr, leaving free cash of ₹379 Cr after ₹135 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 96% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 96%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: the bigger cash user is investment — capital spending ran 1.9× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
3M India Ltd's cash conversion cycle runs 60 days in FY26, down from 60 days in FY21. Capital spending ran ₹323 Cr over the last 3 years. At FY26 sales of ₹5,090 Cr each day of that cycle holds about ₹13.9 Cr, so roughly ₹837 Cr sits inside the business at any moment.
FY26: debtors at 60 days, inventory at 102 days — roughly 3.4 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 60 days, tighter than FY21's 60.
The full loop: cash goes out to suppliers and production on day 0; stock waits 102 days to sell; customers pay about 60 days after that; and suppliers themselves are paid at 102 days — netting out to the 60-day cycle.
In money terms: at FY26 sales of ₹5,090 Cr, each day of the cycle holds about ₹13.9 Cr — so the 60-day loop keeps roughly ₹837 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹323 Cr over the last 3 fiscal years against ₹171 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹14.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
3M India Ltd earns a ROCE of 50% in FY26. That is up from a trough of 9% in FY21. Return on invested capital clears the cost of that capital by +39.0 percentage points, so growth here adds value rather than only size. The wiring behind it is 10.3% net margin on 1.62× asset turns.
FY26 ROCE is 50%, recovered from a FY21 trough of 9% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 10.3% net margin × 1.62× asset turns × 1.77× balance-sheet leverage ≈ 29.5% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 51.0% − 12.0% = a +39.0 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
3M India Ltd carries total debt of ₹170 Cr against shareholder equity of ₹1,768 Cr as of Mar 26, a debt-to-equity of 0.10 — effectively unlevered. On the annual view that ratio went from 0.01 in FY22 to 0.10 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹170 Cr against shareholder equity of ₹1,768 Cr — a debt-to-equity of 0.10. On the annual view, debt-to-equity went from 0.01 (FY22) to 0.10 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of 3M India Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved −0.1 points over the same window, to 8.2%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −0.3 points over 8 quarters to 3.5%; Domestic institutions: −0.1 points over 8 quarters to 8.2%; Promoters: +0.0 points over 8 quarters to 75.0%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
3M India Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Sobhagya Mercantile Ltd512014 | 62.3/100Mixed-positive evidence75% evidence | BREAKING OUT | 15.9/35 Revenue 21.9% · PAT 8.1% · OPM change -0.5 pp 95% evidence | 19.1/25 ROCE 23.4% · OPM 14.4% 76% evidence | 9.3/20 P/E 64.5× · PEG — 15% evidence | 18.0/20 RS sector 32.4% · RS bench 38.6% · 1Y 38.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 19.1 + 9.3 + 18 = 62.3 · Decision use: Price leads the evidence: RS versus the benchmark is 38.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 2Kalind Ltd526935 | 61.1/100Mixed-positive evidence82% evidence | 30.6/35 Revenue 100% · PAT 100% · OPM change 21 pp 95% evidence | 18.2/25 ROCE 32% · OPM 63% 76% evidence | 11.3/20 P/E 13.9× · PEG — 50% evidence | 1.0/20 RS sector -89.7% · RS bench -36.7% · 1Y -79.2%0 of 7 weeks ahead to 2026-08-16 100% evidence | |
| Exact sum: 30.6 + 18.2 + 11.3 + 1 = 61.1 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -89.7% and the one-year return is -79.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Indiabulls LimitedIBULLSLTD | 61.0/100Mixed-positive evidence67% evidence | LEADER | 18.4/35 Revenue 100% · PAT 100% · OPM change 28 pp 71% evidence | 14.1/25 ROCE 16.2% · OPM 43% 76% evidence | 10.4/20 P/E 14.6× · PEG — 15% evidence | 18.1/20 RS sector 54.8% · RS bench 60.8% · 1Y 66.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 14.1 + 10.4 + 18.1 = 61 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Grasim Industries LtdGRASIM | 59.9/100Mixed-positive evidence82% evidence | BREAKING OUT | 24.3/35 Revenue 19.5% · PAT 33.1% · OPM change 1 pp 95% evidence | 13.1/25 ROCE 8% · OPM 23% 76% evidence | 6.8/20 P/E 38.1× · PEG — 50% evidence | 15.7/20 RS sector 6.1% · RS bench 11.3% · 1Y 14.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 24.3 + 13.1 + 6.8 + 15.7 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5BCL Industries LtdBCLIND | 56.5/100Mixed-positive evidence87% evidence | ASLEEP | 20.1/35 Revenue -13.1% · PAT 15.2% · OPM change 3 pp 95% evidence | 14.9/25 ROCE 13.9% · OPM 10% 95% evidence | 13.1/20 P/E 8.4× · PEG — 50% evidence | 8.4/20 RS sector -5.4% · RS bench -0.8% · 1Y -18.2%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 14.9 + 13.1 + 8.4 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Balmer Lawrie & Company LtdBALMLAWRIE | 54.1/100Mixed-positive evidence82% evidence | BASING | 17.1/35 Revenue 8.9% · PAT 3.8% · OPM change 1 pp 95% evidence | 15.1/25 ROCE 14.6% · OPM 13% 76% evidence | 14.5/20 P/E 10.3× · PEG — 50% evidence | 7.4/20 RS sector -10.8% · RS bench -6.3% · 1Y -27.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 15.1 + 14.5 + 7.4 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 73M India Ltdthis page3MINDIA | 52.7/100Mixed-positive evidence94% evidence | TURNING | 21.9/35 Revenue 15.7% · PAT 16.1% · OPM change -3 pp 100% evidence | 18.7/25 ROCE 50% · OPM 17% 100% evidence | 1.8/20 P/E 87.2× · PEG 3.29 100% evidence | 10.3/20 RS sector -3.7% · RS bench 3.3% · 1Y 11%4 of 10 weeks ahead 70% evidence |
| Exact sum: 21.9 + 18.7 + 1.8 + 10.3 = 52.7 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 8Texmaco Infrastructure & Holdings LtdTEXINFRA | 51.9/100Mixed-positive evidence80% evidence | LEADER | 18.9/35 Revenue 5.5% · PAT 100% · OPM change -37.9 pp 95% evidence | 7.4/25 ROCE 1.4% · OPM -48.8% 95% evidence | 8.5/20 P/E 160× · PEG — 15% evidence | 17.1/20 RS sector 7.9% · RS bench 13.2% · 1Y 19.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.9 + 7.4 + 8.5 + 17.1 = 51.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Nurture Well Industries Ltd531889 | 49.1/100Mixed-negative evidence75% evidence | ASLEEP | 19.8/35 Revenue 34% · PAT 27% · OPM change 1 pp 95% evidence | 16.5/25 ROCE 22.9% · OPM 11% 76% evidence | 11.5/20 P/E 8.3× · PEG — 15% evidence | 1.3/20 RS sector -34% · RS bench -30.3% · 1Y 12.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 16.5 + 11.5 + 1.3 = 49.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Bluspring Enterprises LtdBLUSPRING | 43.7/100Thin evidence · provisional57% evidence | BREAKING OUT | 18.8/35 Revenue 11.8% · PAT 90.6% · OPM change 0.7 pp 71% evidence | 4.2/25 ROCE 5.2% · OPM 2.2% 95% evidence | 8.7/20 P/E 122× · PEG — 15% evidence | 12.0/20 RS sector — · RS bench 54.1% · 1Y 55.9%10 of 10 weeks ahead 25% evidence |
| Exact sum: 18.8 + 4.2 + 8.7 + 12 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Nava LtdNAVA | 42.9/100Mixed-negative evidence93% evidence | BASING | 10.0/35 Revenue 9% · PAT -29.9% · OPM change -6 pp 100% evidence | 13.1/25 ROCE 12.8% · OPM 43% 100% evidence | 12.9/20 P/E 21× · PEG 1.16 65% evidence | 6.9/20 RS sector -7.5% · RS bench -3% · 1Y -20.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 10 + 13.1 + 12.9 + 6.9 = 42.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Tube Investments of India LtdTIINDIA | 38.1/100Mixed-negative evidence100% evidence | ASLEEP | 15.6/35 Revenue 17.6% · PAT 6.6% · OPM change -1 pp 100% evidence | 15.4/25 ROCE 17.1% · OPM 9% 100% evidence | 3.0/20 P/E 80.3× · PEG 9.63 100% evidence | 4.1/20 RS sector -10.2% · RS bench -5.8% · 1Y -19.4%2 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 15.4 + 3 + 4.1 = 38.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Bharat Global Developers LtdBGDL | 37.4/100Mixed-negative evidence63% evidence | 8.2/35 Revenue -80% · PAT -80% · OPM change 4.2 pp 95% evidence | 7.2/25 ROCE 0% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.0/20 RS sector 165.8% · RS bench -36.8% · 1Y -58.7%0 of 12 weeks ahead to 2026-08-23 70% evidence | |
| Exact sum: 8.2 + 7.2 + 10 + 12 = 37.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Andrew Yule & Company LtdANDREWYU | 36.1/100Mixed-negative evidence66% evidence | ASLEEP | 14.9/35 Revenue -4.8% · PAT -80% · OPM change 25.9 pp 95% evidence | 3.7/25 ROCE -6.3% · OPM -23.4% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 7.5/20 RS sector -37% · RS bench 10% · 1Y -1.4%5 of 11 weeks ahead 70% evidence |
| Exact sum: 14.9 + 3.7 + 10 + 7.5 = 36.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Kesar Enterprises LtdKESAR | 35.0/100Thin evidence · provisional51% evidence | 14.4/35 Revenue -9% · PAT 34.7% · OPM change -22132 pp 62% evidence | 4.9/25 ROCE -19.5% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.7/20 RS sector -44.4% · RS bench 0% · 1Y -34%0 of 12 weeks ahead to 2026-08-23 70% evidence | |
| Exact sum: 14.4 + 4.9 + 10 + 5.7 = 35 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Swan Corp LtdSWANCORP | 29.0/100Adverse evidence69% evidence | BASING | 8.7/35 Revenue -16.7% · PAT -67.2% · OPM change -2.6 pp 95% evidence | 5.7/25 ROCE -0.6% · OPM -0.4% 76% evidence | 9.8/20 P/E 41.4× · PEG — 15% evidence | 4.8/20 RS sector -29.3% · RS bench -19.6% · 1Y -36.8%0 of 10 weeks ahead 70% evidence |
| Exact sum: 8.7 + 5.7 + 9.8 + 4.8 = 29 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Integrated Industries LtdIIL | 63.7/100Thin evidence · provisional50% evidence | 20.5/35 Revenue 60.5% · PAT 94.6% · OPM change 2 pp 53% evidence | 16.4/25 ROCE 30.5% · OPM 11% 57% evidence | 10.9/20 P/E 11.6× · PEG — 15% evidence | 15.9/20 RS sector 51.9% · RS bench 63.7% · 1Y 135.2%11 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 20.5 + 16.4 + 10.9 + 15.9 = 63.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Arunis Abode LtdARUNIS | 50.8/100Thin evidence · provisional45% evidence | 15.2/35 Revenue 100% · PAT 100% · OPM change -17.7 pp 40% evidence | 9.5/25 ROCE -5.3% · OPM 28.5% 57% evidence | 9.4/20 P/E 62.5× · PEG — 15% evidence | 16.7/20 RS sector 131.3% · RS bench 136.7% · 1Y 193.6%12 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 15.2 + 9.5 + 9.4 + 16.7 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Piramal Enterprises Ltd(Merged)PEL | 45.1/100Thin evidence · provisional41% evidence | 16.7/35 Revenue -35.5% · PAT 100% · OPM change -9.8 pp 27% evidence | 11.1/25 ROCE 4.9% · OPM 77.4% 57% evidence | 9.6/20 P/E 61.4× · PEG — 15% evidence | 7.7/20 RS sector -20.3% · RS bench 1% · 1Y 3.7%6 of 12 weeks ahead to 2025-09-24 70% evidence | |
| Exact sum: 16.7 + 11.1 + 9.6 + 7.7 = 45.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Rossell India LtdROSSELLIND | 42.6/100Thin evidence · provisional47% evidence | 14.8/35 Revenue 4.8% · PAT -41.1% · OPM change 0.1 pp 36% evidence | 11.7/25 ROCE 6.4% · OPM 10.7% 71% evidence | 10.8/20 P/E 11.8× · PEG — 15% evidence | 5.3/20 RS sector -28.8% · RS bench -19.6% · 1Y -29.3%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 14.8 + 11.7 + 10.8 + 5.3 = 42.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is 3M India Ltd's share price today?
3M India Ltd trades at ₹34,095, +14.0% over the past year. The company is valued at ₹38,425 Cr. The stock sits at 57% of its 52-week range of ₹29,560–₹37,505, +2.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 10 weeks in. — as of 18 September 2026.
What were 3M India Ltd's latest quarterly results?
3M India Ltd reported revenue of ₹1,423 Cr and net profit of ₹233 Cr for the Jun 26 quarter. Revenue rose 19.0% and profit rose 30.9% year on year. Earnings per share were ₹206.90. The operating margin was 17.0%, 3.0 pp lower than a year earlier. — as of 18 September 2026.
What is 3M India Ltd's revenue?
3M India Ltd reported revenue of ₹1,423 Cr in the Jun 26 quarter, +19.0% year on year. For the full FY26 fiscal year, revenue was ₹5,090 Cr (+14.5%). Over the last 10 years revenue compounded at 9.1% a year. — as of 18 September 2026.
What is 3M India Ltd's profit?
3M India Ltd earned ₹233 Cr of net profit in the Jun 26 quarter, +30.9% year on year — the 2nd straight quarter of growth. Full-year FY26 profit was ₹522 Cr. The operating margin ran 17.0% in the latest quarter. — as of 18 September 2026.
What is 3M India Ltd's market cap?
3M India Ltd's market capitalisation is ₹38,425 Cr at a share price of ₹34,095. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 18 September 2026.
What is 3M India Ltd's P/E ratio?
3M India Ltd trades at a P/E of 87.2×, at the 80th percentile of its own 10-year range, against a long-run median of 72.7×. This is a comparison with the stock's own history, not a value call — as of 18 September 2026.
Does 3M India Ltd pay a dividend?
Yes — 3M India Ltd's dividend payout was 109% of profit in FY26, and it recorded a payout in 4 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 18 September 2026.
Is 3M India Ltd overvalued?
On its own history, 3M India Ltd looks expensive: its P/E of 87.2× sits at the 80th percentile of its 10-year range (long-run median 72.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 18 September 2026.
Is 3M India Ltd growing?
Yes — 3M India Ltd is growing: latest-quarter revenue +19.0% year on year, profit +30.9%, and the margin −3.0 pp at 17.0%. The 10-year compound rates are 9.1% (revenue) and 10.3% (profit). The earnings engine currently reads: improving — as of 18 September 2026.
How is 3M India Ltd performing?
3M India Ltd is in a confirmed uptrend, 10 weeks in. Its latest quarter's revenue rose 19.0% and profit rose 30.9% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 18 September 2026.
What stage is 3M India Ltd in?
Turning around — profit growth swung from −17.0% at the trough to +16.1%, a 3-quarter improving streak, ROCE lifting at 47.5%. The read comes from the last 12 quarters of growth (revenue growth +15.7% latest, profit growth +16.1% latest, eps growth +16.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 18 September 2026.
Is 3M India Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 10 of stage 2), trading +2.1% versus its 200-day average and at 57% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 18 September 2026.
Is 3M India Ltd beating the market?
On recent form, yes — 3M India Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +216% against the NIFTY 500's +264% — behind the index over the full window. — as of 18 September 2026.
Will 3M India Ltd's share price go up?
This page publishes no price forecast for 3M India Ltd. What it measures instead: the share price is ₹34,095, the price is in a confirmed uptrend 10 weeks in. Its P/E of 87.2× sits at the 80th percentile of its own 10-year range. — as of 18 September 2026.
Who owns 3M India Ltd?
Promoters hold 75.0% of 3M India Ltd, foreign institutions 3.5%, domestic institutions 8.2% and the public 13.3% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 18 September 2026.
Does 3M India Ltd have too much debt?
No — 3M India Ltd's debt-to-equity is 0.10, and operating profit covers the interest bill 22×. FY26 borrowings were ₹170 Cr against equity of ₹1,768 Cr. The returns on this page are earned, not borrowed — as of 18 September 2026.
What is 3M India Ltd's capex?
3M India Ltd spent ₹323 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹135 Cr, with ₹14.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 18 September 2026.
What is 3M India Ltd's cash flow?
3M India Ltd generated ₹514 Cr of operating cash flow in FY26 and ₹379 Cr of free cash flow after ₹135 Cr of capital spending. Reported profit that year was ₹522 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 18 September 2026.
Is 3M India Ltd's profit real cash?
Yes — over the last 3 fiscal years, 96% of 3M India Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹514 Cr against reported profit of ₹522 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 18 September 2026.
Where is 3M India Ltd in its business cycle?
3M India Ltd's FY26 operating margin was 19.0%, against a 13-year band of 6.0%–19.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 17.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 18 September 2026.
What growth does 3M India Ltd's price assume?
At its price on 13 June 2026, 3M India Ltd was priced for profit growth of about 30.1% a year. Profit itself has compounded 10.3% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 18 September 2026.
What could break the 3M India Ltd story?
The sharpest disagreement: the engine is strong, but at the 80th percentile of its own range you are paying full price for it. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 18 September 2026.
Is 3M India Ltd a stock worth studying right now?
This is not investment advice. The machine read: 3M India Ltd is strength at full price. The numbers are improving — and a P/E at the 80th percentile of its own range says the market knows. The sharpest open question: whether the earnings grow into the multiple. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 18 September 2026.
Not SEBI Registered !! Not Investment advice !!